Morgan Stanley Immuno Precise Antibodies Ltd. Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Morgan Stanley holds 12,533 shares of IPA stock, worth $6,893. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,533
Previous 12,533
-0.0%
Holding current value
$6,893
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IPA
# of Institutions
26Shares Held
3.93MCall Options Held
27.2KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.76MShares$1.52 Million0.03% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA703KShares$386,6500.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.6KShares$49,8200.0% of portfolio
-
Virtu Financial LLC New York, NY57.8KShares$31,8150.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$22,6600.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $13.7M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...